U.K.-based private equity firm Permira is acquiring shares in BioCatch primarily from existing investors like Bain Capital, Maverick Ventures, and Tech Opportunities, valuing BioCatch at $1.3 billion.
Permira last year acquired a significant minority stake in BioCatch, becoming its No. 3 shareholder. This recent deal marks Permira's largest known transaction since taking Mimecast private for $5.8 billion.
Thoma Bravo recently announced the acquisition of Darktrace in a $5 billion deal. BioCatch, established in 2011, develops technology to help banks identify real customers from fraudsters using online behavior analysis.
Permira plans to bring a growth mindset to BioCatch, aiming to expand further across Europe. BioCatch has raised over $200 million to date, with investments from major financial institutions like American Express and Barclays.
[
add
]
[
|
|
...
]